Binding Immunoglobulin Protein (BiP), also known as Glucose-Regulated Protein 78 (GRP78) or HSPA5, is the master endoplasmic reticulum (ER) chaperone and the central regulator of the unfolded protein response (UPR). BiP is an HSP70 family ATPase that binds to unfolded and misfolded proteins in the ER lumen, facilitating proper protein folding, assembly, and quality control.[1][2]
In neurodegenerative diseases, BiP serves as both a sensor of ER stress and a protective factor against protein aggregation. Changes in BiP expression and function are observed in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, making it a potential therapeutic target and biomarker.[3]
BiP is composed of two major domains:
Nucleotide-Binding Domain (NBD): The N-terminal 44 kDa domain contains the ATPase activity. ATP binding and hydrolysis regulate the conformational changes that control substrate binding and release. Contains conserved Walker A and Walker B motifs.
Substrate-Binding Domain (SBD): The C-terminal 25 kDa domain binds to hydrophobic stretches on unfolded proteins. Comprises:
The two domains are connected by a hydrophobic linker. ATP binding to the NBD triggers conformational changes that open the SBD, releasing the substrate. ATP hydrolysis closes the lid, trapping the substrate for folding.[4]
BiP function is regulated by ER-resident co-chaperones:
BiP performs essential functions in the ER:
BiP is the master regulator of all three UPR sensors:
This elegant mechanism ensures that the UPR is activated only when misfolded proteins accumulate and compete for BiP binding.[6]
In Alzheimer's disease, BiP expression is increased in affected brain regions:
Post-mortem studies show elevated BiP immunoreactivity in AD hippocampus and cortex, particularly in neurons containing neurofibrillary tangles.
In ALS:
In cancer, GRP78 can translocate to the cell surface and act as a signaling receptor. Similar phenomena may occur in stressed neurons, representing both a vulnerability and therapeutic opportunity.
Gething & Sambrook, BiP (GRP78) molecular chaperone (1992). 1992. ↩︎
Lee et al. Role of BiP in ER stress and neurodegeneration (2005). 2005. ↩︎
Kimata & Kohno, BiP and the unfolded protein response (2011). 2011. ↩︎
Yang J, et al. Conformational cycling of BiP. Nat Struct Mol Biol. 2018. ↩︎
Wei J, Hendershot LM. [Protein folding and assembly in the endoplasmic reticulum](https://doi.org/10.1016/0014-5793(96). FEBS Lett. 1996. ↩︎
Bertolotti A, et al. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol. 2000. ↩︎
Hoozemans JJ, et al. The unfolded protein response is activated in Alzheimer's disease. Ann Neurol. 2005. ↩︎
Colla E, et al. Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo. J Neurosci. 2012. ↩︎
Thomas M, et al. Huntingtin's disease: protein-protein interactions and the unfolded protein response. Neurobiol Dis. 2010. ↩︎
Gupta S, et al. GRP78 (BiP) as a therapeutic target in neurodegenerative diseases. Antioxid Redox Signal. 2020. ↩︎